Market Overview

20 Stocks Moving In Monday's Pre-Market Session

Share:

Gainers

  • AveXis, Inc. (NASDAQ: AVXS) rose 85.1 percent to $214.60 in pre-market trading after the company agreed to be acquired by Novartis AG (NYSE: NVS) for $8.7 billion.
  • Therapix Biosciences Ltd. (NASDAQ: TRPX) rose 32.5 percent to $6.60 in pre-market trading after the company disclosed topline results of Phase IIa study at Yale University for Tourette Syndrome program.
  • REGENXBIO Inc. (NASDAQ: RGNX) rose 23 percent to $33.45 in pre-market trading after dropping 3.89 percent on Friday.
  • Verastem, Inc. (NASDAQ: VSTM) shares rose 22.3 percent to $3.62 in pre-market trading after the company disclosed that the FDA has accepted New Drug Application for duvelisib.
  • Cellect Biotechnology Ltd. (NASDAQ: APOP) rose 16.8 percent to $7.58 in pre-market trading after the company reported that it has successfully completed a Proof of Concept study for ApoTainer.
  • Audentes Therapeutics, Inc. (NASDAQ: BOLD) rose 9.8 percent to $30.86 in pre-market trading after dropping 2.87 percent on Friday.
  • Senseonics Holdings, Inc. (NASDAQ: SENS) shares rose 7.5 percent to $4.00 in pre-market trading after gaining 5.68 percent on Friday.
  • Marrone Bio Innovations, Inc. (NASDAQ: MBII) shares rose 7.1 percent to $3.48 in pre-market trading after jumping 21.72 percent on Friday.
  • Portola Pharmaceuticals, Inc. (NASDAQ: PTLA) rose 6.8 percent to $33.00 in pre-market trading after falling 4.01 percent on Friday.
  • JinkoSolar Holding Co., Ltd. (NYSE: JKS) rose 6.3 percent to $20.31 in pre-market trading after falling 4.64 percent on Friday.
  • bluebird bio, Inc. (NASDAQ: BLUE) shares rose 5.7 percent to $172 in pre-market trading after falling 4.38 percent on Thursday.
  • Leucadia National Corporation (NYSE: LUK) rose 4.4 percent to $22.73 in pre-market trading after the company agreed to sell 48 percent of National Beef for $1.05 billion and its stake in Garcadia for $425 million. The company also announced a 25 million share buyback plan.
  • Deutsche Bank AG (USA) (NYSE: DB) shares rose 3.8 percent to $14.40 in pre-market trading after the bank named Christian Sewing as its new CEO. The bank’s new CEO announced plans to review investment banking business.
  • Merck & Co., Inc. (NYSE: MRK) rose 3.1 percent to $54.97 in pre-market trading after the company disclosed that its KEYTRUDA monotherapey met its primary endpoint in the Phase 3 KEYNOTE-042 study.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Menlo Therapeutics Inc. (NASDAQ: MNLO) fell 51.7 percent to $17.00 in pre-market trading as the company disclosed that its Phase 2 trial of serlopitant for pruritus associated with atopic dermatitis did not meet primary and key secondary efficacy endpoints.
  • New York Times Company (NYSE: NYT) fell 6.8 percent to $22.00 in pre-market trading after rising 2.39 percent on Friday.
  • Broadwind Energy, Inc. (NASDAQ: BWEN) fell 6.3 percent to $2.84 afterclimbing 28.94 percent on Friday.
  • Sibanye Gold Limited (NYSE: SBGL) shares fell 6 percent to $3.75 in pre-market trading after rising 3.37 percent on Friday.
  • SSLJ.com Limited (NASDAQ: SSLJ) fell 5.2 percent to $4.93 in pre-market trading after dropping 2.80 percent on Friday.
  • Yandex N.V. (NASDAQ: YNDX) shares fell 4.9 percent to $37.47 in pre-market trading after declining 1.84 percent on Friday.

Posted-In: #PreMarket Gainers LosersNews Movers & Shakers Pre-Market Outlook Markets Movers Trading Ideas

 

Related Articles (AVXS + APOP)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

Eyenovia CEO Talks Temporary Distraction Of IPO, Pipeline Opportunity

A Peek Into The Markets: US Stock Futures Signal Higher Start On Wall Street